Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2006; 12(30): 4850-4858
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4850
Figure 2
Figure 2 DA-9601 inhibits the expression and secretion of CCL20 in AGS cells. (A) AGS cells (1 x 105) were treated with various concentrations of DA-9601 (0-100 μg/mL) for 16 h. Quantitative analysis of cell viability was determined by the MTT assay (mean ± SD., n = 3). (B) Cells (5 x 105) were pretreated with various concentrations of DA-9601 (0-100 μg/mL) for 1 h, and then the cells were further incubated for 8 h with TNF-α (5 ng/mL). Levels of IL-8 and CCL20 mRNAs were determined by RT-PCR. (C) Cells (5 x 105) were pretreated with various concentrations of DA-9601 (0-100 μg/mL) for 1 h, and then the cells were further incubated for 16 h with TNF-α (5 ng/mL). IL-8 and CCL20 protein levels were determined by ELISA. These data are representative of three independent experiments.